![Stuart McLachlan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stuart McLachlan
Corporate Officer/Principal en Lypanosys Pte Ltd. .
Perfil
Stuart McLachlan is currently working as the Executive Vice President-Clinical Trials at Lypanosys Pte Ltd.
He holds a doctorate degree from the University of California, Davis.
Cargos activos de Stuart McLachlan
Empresas | Cargo | Inicio |
---|---|---|
Lypanosys Pte Ltd.
![]() Lypanosys Pte Ltd. Pharmaceuticals: MajorHealth Technology Lypanosys Pte Ltd. engages in the development of clinically differentiated drug for dermatology. Its initial drug compound, LYP-010 is formulated as an oral systemic drug for the treatment of atopic dermatitis. The company was founded in 1997 and is headquartered in Singapore. | Corporate Officer/Principal | 06/06/2011 |
Formación de Stuart McLachlan.
University of California, Davis | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Lypanosys Pte Ltd.
![]() Lypanosys Pte Ltd. Pharmaceuticals: MajorHealth Technology Lypanosys Pte Ltd. engages in the development of clinically differentiated drug for dermatology. Its initial drug compound, LYP-010 is formulated as an oral systemic drug for the treatment of atopic dermatitis. The company was founded in 1997 and is headquartered in Singapore. | Health Technology |
- Bolsa de valores
- Insiders
- Stuart McLachlan